Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by PharmAla Biotech
PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002
August 09, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
April 05, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office
March 27, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
March 20, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
March 18, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
MDXXF
PharmAla receives new “MDXXF” ticker from FINRA for OTCQB Listing
January 24, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance
January 08, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
PMBHF
PharmAla Begins Trading on OTCQB
September 06, 2023
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
PMBHF
PharmAla Files Patent for Novel MDXX Molecule PharmAla-1
July 31, 2023
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
PMBHF
USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States
June 09, 2023
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
PMBHF
PharmAla Biotech to form Australian Psychedelics Joint Venture with Vitura Health
May 01, 2023
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
ASX:VIT
CSE:MDMA
Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change
February 03, 2023
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
November 16, 2022
From
PharmAla Biotech
Via
GlobeNewswire
Tickers
CSE:MDMA
CSE:MSET
MSSTF
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.